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INTRODUCTION
Since the early 1960´s, pharmaceutical solid dispersions (SDs) have been brought up as a potential alternative formulation approach for poorly water-soluble drugs. In the well-known pioneering study, Sekiguchi and Obi (1961) discovered that the oral administration of eutectic mixtures of sulfathiazole and urea (obtained by a co-fusion method) resulted in enhanced drug absorption in healthy adults compared to sulfathiazole alone (Sekiguchi and Obi, 1961) . Within the next two-three decades, interest in pharmaceutical SDs was steadily increased due to the encouraging reports on the use of SDs with poorly soluble drugs. More recently, the next generation SDs containing surfactant carrier(s) and/or amorphous polymer(s) have been introduced (Vasconcelos et al., 2007) .
In pharmaceutical sciences, the term "SD" refers to both solid one-phase homogeneous molecular mixtures and phase-separated suspended mixtures of drug and inert carrier material The desired SD structure for improving drug dissolution would be one-phase homogeneous solid solution (Brough and Williams, 2013) . However, the opposite effect has been observed with one-phase SDs with no detectable drug dissolution due to the formation hydrogen bonds between the drug and carrier material (Surwase et al., 2015) . Two-phase glassy suspensions and amorphous precipitation systems may circumvent this problem, and thus, they have also a great potential to achieve these goals (Thommes et al., 2011; Thommes, 2012) . In addition, two-phase systems enable to incorporate higher drug loadings in a SD matrix. Several carrier for the melt method has the following characteristics: inert, thermostable, high glass transition temperature (T g ), soluble in water, and capable for solubilizing and stabilizing drugs. In our previous study, we showed that melting the drug first, and then adding a carrier material with subsequent quench cooling (QC) resulted in two-phase amorphous systems with a moderate physical stability (Semjonov et al., 2017 Since pharmaceutical SDs are virtually always used in a powder form, a deeper understanding of the particle properties (i.e., particle size and size distribution, shape, surface morphology, surface area) and bulk powder behavior (i.e., powder flow, moisture sorption, caking, wetting, dissolution) associated with such powders is of critical importance.
in-vivo
To date, however, the studies dealing with the interactions of amorphous SD powders with air/water as well as the particle and bulk powder behavior of SDs are scarce. The particle size is a crucial characteristic of pharmaceutical powders influencing the dissolution of a poorly water- The primary goals of the present study were (1) to investigate the particle properties and bulk powder behavior of the QC molten two-phase SDs of a poorly water-soluble drug (IND) with two different carrier materials (SOL and XYL), and (2) to elucidate the impact of these material properties on the formulation and performance of such SDs. A particular attention was paid to the effects of the matrix formers (amorphous hydrophilic polymer vs crystalline sugar alcohol) and a QC melt (co-fusion) method on the particle properties and bulk powder behavior of SDs.
MATERIALS AND METHODS

Materials
The γ-polymorphic form of IND (γ-IND) (NLT 97.5%, Acros Organics, England) was used as a poorly water-soluble model drug. The α-polymorphic and amorphous forms of a model drug were prepared as described in our previous study (Semjonov et al., 2017) . Soluplus ® (BASF SE Pharma Ingredients & Services, Germany) was used as a solubilizing polymeric matrix former. Xylitol (Ph.Eur.) was used as a small-molecule freely soluble SD matrix former. Table 1 summarizes the physicochemical properties of IND and SD carrier materials.
Fabrication of SDs and physical binary mixtures (PMs)
Pure materials were manually sieved (150 µm) prior to further use and characterization.
The preparation of the QC molten SDs and corresponding PMs has been presented in detailed elsewhere (Semjonov et al., 2017) . Hence two-phase systems were obtained instead of molecularly dispersed SDs. 
Moisture content analysis
Karl-Fischer (KF) titration (Mettler Toledo V30 Volumetric KF Titrator, Mettler-Toledo GmbH, Schwerzenbach, Switzerland) was used for determining the total water content of materials. The KF titrations (n = 2-3) were carried out at 21 °C temperature / 22% relative humidity (RH).
Contact angle measurements
Contact angle measurements (CAM200, ver. 4.1, KSV Instruments, Finland) were performed with the flat-faced compacts (m = 300 mg) prepared using a tabletop hydraulic press with a 13-mm die. Each compact was pressed using 100 MPa of pressure for 30 s. A purified water drop (MilliQ, EMD Millipore Corporation, Billerica, MA, USA) was used as the testing liquid. Images were taken within 40 ms after the liquid drop touched the surface of the compact, and both angles were recorded.
Moisture sorption
The 
where S is the initial mass of the sample, w i is the total original mass of a petri dish and the sample, and w f is the total end mass of a petri dish and the sample. Total three parallel determinations were made.
Scanning electron microscopy
Scanning electron microscope (SEM) (Zeiss EVO MA 15, Germany) was exploited for imaging the particle size, shape, surface porosity and morphology of the samples. The samples were attached on a carbon tape, and sputter coated with platinum (3-5 nm) in an argon atmosphere. The measurements were carried out under low vacuum. Martin's diameter of 50 randomly selected particles was determined in vertical direction from SEM images and particle size was measured by Image J (NIH, USA).
Powder flow test
The powder flow was determined using a novel in-house flow testing device (Fig. 1) . The flow testing device has a sample cuvette mounted on a stepper motor, which was controlled with custom-made software. The cuvette consisted of two vertically positioned chambers separated by a 3 mm orifice. The powder was placed in the left chamber, and the cuvette was subjected to a specific acceleration profile, consisting of a slow acceleration and rapid deceleration when moving to the right and a rapid acceleration and slow deceleration when moving to the left. As a result of the acceleration profile and based on Newtonian mechanics, the powder is able to gradually move to the opposite chamber through the orifice. When the powder was completely transferred to the opposite chamber, the measurement was terminated. The result was expressed as the amount of powder transferred per movement (mg/movement). The acceleration profile was programmed using MATLAB (The MathWorks, Inc., Natick, MA, USA). The testing method was validated with known excipients and against comparable powder flow measurements found in the literature (Seppälä et al., 2010) . 
Dissolution test in vitro
The dissolution tests were carried out using an USP paddle method (Distek Dissolution system 2100B, Distek, Inc., NJ, U.
S.A). A table-top UV-VIS spectrophotometer (Specord 200
plus, AnalyticJena, Germany) was used at the analytical wavelength of 370 nm for the analysis of the PM and SD samples (n = 3). Prior to experiments, it was verified that neither SOL nor XYL showed any absorption at this specific wavelength. The two buffer solutions (Ph.Eur.), pH 1.2 and pH 6.8, were used as a dissolution medium at 37.0 ± 0.5 °C. The total volume of the medium in each dissolution vessel was 500 ml and the amount of powder mass used for testing was 400 mg (100 mg for pure IND). The rotation speed of the paddles was set at 100 rpm. At regular time intervals (10, 20, 30, 60, 360 , and 1440 min), the samples of 5 ml were manually collected with a syringe and replaced accordingly with the pure buffer solution in a dissolution vessel. The samples were filtered using a 25-mm syringe filter (VWR, USA) and through cellulose filters with a pore size of 45 µm. The first 2 ml of the filtrated solution was not included in the quantitative analysis with a UV-VIS spectrophotometer.
Data analysis
ImageJ (vers. 1.50i) was applied for measuring the particle size of samples, and a normality distribution was checked with a Shapiro-Wilk test. The mean values of particle size and drug release (% dissolved) were compared with a t-test. The statistical analysis (p ˂ 0.05) of contact angle results was performed with a ANOVA one-way test and Tukey test.
RESULTS AND DISCUSSION
Particle properties
Virtually all critical pharmaceutical bulk powder properties, such as flowing, segregation, adhesion, water sorption and dissolution are dependent on the particle size, shape and surface morphology of the powder mixture (Mosharraf and Nyström, 1995) . The SDs with SOL showed oval shaped fused particles or agglomerates (Fig. 3A2) . The
SDs of IND and XYL possessed much larger particles with a rough surface coming from the surface recrystallization of XYL (Fig. 3B2) . It is obvious that the topographical differences between the SDs consisting of different carrier materials are due to the differences in material properties. Palomäki et al. (2016) showed that amorphous XYL recrystallizes within five minutes at a room temperature (RT). Taking into consideration this fast XYL recrystallization tendency and the fact that the sample was ground after QC melting, the present XYL containing SDs are crystalline. The crystalline state of such SDs was confirmed in our previous study with X-ray powder diffraction complemented with FTIR spectroscopy (Semjonov et al., 2017). According to the Shapiro-Wilk test, the particle size of the present samples measured with SEM did not follow a normal distribution (α = 0.05) (the particle size distributions are shown in Fig. 4) . The difference between the particle size of PMs and respective SDs was statistically significant with both SOL and XYL carrier materials (p ˂ 0.05). However, the statistical analysis did not show any significant difference between the particle size of SDs with SOL and XYL. 
Residual water content
The moisture content and wetting of pharmaceutical powders can essentially affect the bulk powder behavior, manufacturing, performance and stability of a final pharmaceutical dosage form. (Fig. 5) . With the PMs of γ-IND and XYL, the water content was virtually independent of the amount of the carrier used (Fig. 5) . 
Moisture sorption analysis
The results of moisture sorption analysis are shown in Fig. 6 . As expected, amorphous IND was found to be more hygroscopic (1.3-2% increase in weight gain) than γ-IND. The corresponding increase in weight gain for SOL and XYL was 13-18% and 34-89%, respectively.
The pure materials were exposed to high 95% RH for 7 days, but the equilibrium was reached already within 96 hours, with an exception of XYL which continued to rapidly absorb moisture for up to 144 hours (89%). 
Wetting properties
No statistically significant differences between the contact angle values of γ-IND (51.9° ± 16.6°), α-IND (63.8° ± 8.4°), and amorphous IND (54.9° ± 4.5°) were found (Fig. 7) . 
Powder flow
To date, very little is known on the bulk powder flow properties of the QC molten SDs of the drug and carrier materials. In our study, the powder flow was evaluated using an in-house automated cuvette rheometer designed for testing in a small scale (Fig. 1). Fig. 8 shows the dependence of the number of cuvette movements and the sample mass in the chambers, thus quantifying the powder flow rate (mg/movement) of the sample. As expected, the powder flow of As the amount of the carrier material was increased, the powder flow of the PMs significantly improved (Fig. 8) . The PMs of γ-IND and SOL with the highest drug-polymer ratio (1:9) showed the highest powder flow rate (21.2 mg / movement), while the powder flow rate of the PMs (3:1) was the poorest (6.0 mg / movement) (Fig. 8A) . (Fig. 8) . This could be explained by the larger average particle size and more spherical shape (oval) of the SDs compared to that of PMs ( Fig. 3 and Fig. 4) . Djuris et al. (2013) showed that the SDs of SOL advanced the powder flow properties of carbamazepine (Djuris et al., 2013) . Dabbagh and Taghipour (2007) reported that the SDs of ibuprofen and PEG have superior powder flow properties over the corresponding PMs, and the authors suggested that SDs can be used for promoting the bulk powder flow of the drug. In our study, the moisture content of the SDs (SOL) was somewhat smaller than that observed with the respective PMs (Fig. 5) . Nevertheless, it is evident, that the difference in particle size and morphology is the major factor leading to the differences in the powder flow of SDs and PMs.
The powder flow properties of the SDs of IND and XYL (1:3), and the corresponding PMs were very similar (Fig. 8) . This could be explained by the crystallization of XYL from the SDs resulting in the SD bulk powder with similar properties as PMs. The water content of the samples showed only small differences and moisture sorption was also alike. Indeed, the particles of the SDs were larger compared to those of the PMs, but the adhesion of IND particles to the surface of XYL particles in the PMs unified the surface roughness of the PM and SD particles.
The particles with smooth surfaces were observed with both PMs (XYL) and SDs (XYL) (as shown in Fig. 3 ) which could explain their similar flow properties. According to the literature, the adhesion and friction forces between the drug and carrier material are greatly dependent on the surface roughness of the particles (Podczeck, 1998 ). Genina and co-workers (2009) revealed that the particle surface engineering with ultrasonic water mist improved the powder flow of lactose due to particle surface smoothing and loss of fines. 
Dissolution
The Biopharmaceutics Classification System (BCS) deploys IND among the class II drugs which are characterized by slow or partial dissolution and fast absorption in vivo (Amidon et al., 1995) . Accordingly, with the present drugs dissolution is a critical attribute governing their oral bioavailability and therapeutic effect. Craig (2002) reported that the drug-loaded SDs can present primarily (1) the carrier-controlled dissolution (especially at low drug loadings), or (2) drugdependent dissolution. The prevalence of the release mechanism is dependent on the miscibility and solubility of the components in the concentrated solution of the polymer (Craig, 2002) . In addition, several processes competing with one another take place simultaneously during the dissolution of SDs, and both the drug and carrier polymer properties affect the total drug release (Kogermann et al., 2013) .
As seen in compared to that of the corresponding PMs (11.7 ± 1.7%), although the smaller particle size should have favored the PM. As shown, the SDs had also significantly improved wettability over the corresponding PMs (Fig. 6) . This enhanced dissolution is obviously as a result of improved wetting of IND and inhibited crystallization of the drug from amorphous form or from solution to α form by SOL. Over 85% of the drug was released from the SDs of IND and SOL within 6 h (360 min) of the dissolution test (Fig. 9A) . It is known that molecular mixing between IND and SOL in one-phase SD completely inhibited drug release (Surwase et al., 2015). The release of IND from the corresponding PMs within the first 10 min was close to that obtained with pure γ-dissolution supported by absorption and wetting studies ( Fig. 6 and 7) The difference in drug release of the SDs of IND and XYL (1:3) after 10 min was not statistically significant compared to the corresponding PMs (Fig. 9B) . At 30 min, the difference in the dissolution between the PMs and SDs was even more pronounced (76.3 ± 3.1% and 63.9 ± 2.9%, respectively). The drug release was improved with XYL containing PMs and SDs (Fig. 9B) 
Comparison of the dissolution behavior of two-phase QC SDs
We found that the dissolution behavior of SOL and XYL systems are affected by carrier specific characteristics and solid state form of the drug. Strong H-bonds between the drug and SOL hindered drug release from PMs, unlike with XYL PMs. The plateau effect detected with SOL SDs was not the case with XYL SDs, as drug released steadily up to 360 min. Even though, the initial dissolution rate was faster for SOL SDs, but overall increased amount of drug was released with XYL SDs.
CONCLUSION
